Whether an infection passes or stays is decided as much by the host as by the microbe — and the host genes that decide it are usually the ones that show the immune system what it is fighting.
Why this topic Five years of everyone having an opinion about immunity, and the durable part of it is old: HLA, and why two people meet the same virus and do not get the same illness.
2026-03-06 · Haapaniemi H, et al., Nature Communications 2026, PMID:41792138
Fungal skin infection runs partly in the genes — HLA among the top signals
Athlete's foot, nail fungus and ringworm affect around 20% of people. A meta-analysis of over 250,000 cases found 30 loci, with HLA-DQB1 among the top signals beside skin-barrier genes and FTO: the host decides as much as the fungus. 19 of its positions have pages on this site.
2026-02-19 · Schmidt A, et al., Nature 2026, PMID:41714741
Host control of persistent Epstein-Barr virus infection
EBV reads pulled out of ordinary blood-based genome sequencing in 486,315 UK Biobank and 336,123 All of Us participants (16.2% and 21.8% positive, tracking viral load in blood cells). Genome-wide: 54 independent HLA alleles in the MHC and 27 regions outside it, with HLA class I burden higher in multiple sclerosis (HLA-A*02:01) and class II in rheumatoid arthritis. Four of the non-MHC positions are on this site: rs13098877 (LPP), rs884186 (KSR1), rs9828869 (near ILDR1), rs34557412 (TNFRSF13B).
2026-08-18 · Frontiers in Immunology 2026, PMID:42682600
An HLA-DQB1 Amino Acid Position Protects Against Silent, Antigen-Negative Hepatitis B Infection
High-resolution HLA genotyping in a Chinese cohort (239 occult hepatitis B cases, 545 healthy controls) found the HLA class II allele DQB1*06:02 protective against occult HBV infection (OBI) -- a form where the virus persists without detectable surface antigen, harder to catch than typical chronic hepatitis B. The protective effect traces largely to position 119 in the HLA-DQB1 peptide-binding groove; conversely, the DRB1*09:01 haplotype was linked to higher infection risk. Another real example of HLA class II shaping whether a hepatitis infection is cleared, persists visibly, or persists silently -- this site's chronic-hepatitis-b page covers the typical chronic form.
Solid lines are connections this site curates. Dashed lines mean the two ends share a research paper — worth knowing, and not a claim that one explains the other.
Counted in Europe PMC, where the title or abstract names both this topic and that rsID. The number is papers, not evidence of a cause.
IL29
Chronic hepatitis C infection
100 papers →HLA-DPA1
Hepatitis B
60 papers →HLA-DPB1
Hepatitis B (viral clearance)
55 papers →ITPA
Chronic hepatitis C infection
35 papers →HLA-DQB1
Chronic hepatitis B infection
27 papers →UBE4B
Hepatocellular carcinoma
11 papers →TGFB1
Colorectal cancer
9 papers →HLA-DQA2
Crohn's disease
8 papers →HLA-C
Hepatitis B
6 papers →MERTK
Hepatitis C induced liver fibrosis
6 papers →ALDH2
Alcohol flush reaction
6 papers →HLA-DQB1
Follicular lymphoma
5 papers →MTHFR
Folate metabolism (MTHFR C677T)
5 papers →GC
Vitamin D levels
5 papers →PARVB
Hematological and biochemical traits
4 papers →SCARB1
Lipoprotein-associated phospholipase A2 activity and mass
3 papers →HLA-DQA2
Knee osteoarthritis
3 papers →DARC
Monocyte chemoattractant protein-1 levels
3 papers →ATG16L1
Crohn's disease
3 papers →C6orf10
Ulcerative colitis
3 papers →TERT
Lung adenocarcinoma
3 papers →IL7R
Ulcerative colitis
3 papers →CCR5
HIV-1 resistance (CCR5-delta32)
3 papers →STAT4
Type 1 diabetes
3 papers →HLA-DPA3
Chronic hepatitis B infection
3 papers →HLA-DQA1
Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection
3 papers →IL23R
Crohn's disease
2 papers →STAT4
Systemic lupus erythematosus
2 papers →ADH1B
Alcohol metabolism speed
2 papers →RNF7
Hepatitis C induced liver fibrosis
2 papers →MTHFR
Folate metabolism (MTHFR A1298C)
2 papers →IFIH1
Type 1 diabetes
2 papers →near FAP
Ulcerative colitis
2 papers →ZDHHC11
Pancreatic cancer
2 papers →IFIH1
Psoriasis
2 papers →Unknown
Crohn's disease
2 papers →SLCO1B1
Statin muscle-side-effect risk
2 papers →APOE
Lewy body disease
2 papers →PRDM1
Systemic lupus erythematosus
2 papers →INTS10
Persistent hepatitis B virus infection
2 papers →NCF1
Systemic lupus erythematosus
2 papers →FBN2
Systemic lupus erythematosus
2 papers →IFNGR2
Multiple sclerosis
2 papers →TERT
Breast cancer
1 paper →CD58
Systemic lupus erythematosus
1 paper →APOB
Triglycerides
1 paper →TNPO
Systemic sclerosis
1 paper →STAT6
Allergic sensitization
1 paper →LAMC1
Colorectal cancer
1 paper →SCARB1
Vitamin E levels
1 paper →PRKD2
Chronic lymphocytic leukemia
1 paper →GNL3
Osteoarthritis
1 paper →ATM
Response to metformin in type 2 diabetes (glycemic)
1 paper →HLA-DRB1
Skin and soft tissue Staphylococcus aureus infection
1 paper →KIR2DL1
Inflammatory bowel disease
1 paper →GRIN2A
Hepatitis B
1 paper →SLC16A9
Uric acid levels
1 paper →PVT1
Follicular lymphoma
1 paper →HLA-DPB1
Systemic lupus erythematosus
1 paper →near POU5F1B
Prostate cancer
1 paper →CETP
HDL Cholesterol - Triglycerides (HDLC-TG)
1 paper →BCL2
Follicular lymphoma
1 paper →HNF4A
C-reactive protein levels
1 paper →ABCA1
HDL cholesterol
1 paper →HPR
LDL cholesterol
1 paper →near PPT2
Serum total protein levels
1 paper →ACCS
IgA nephropathy
1 paper →TNIP1
Systemic sclerosis
1 paper →TERT
Prostate cancer
1 paper →YDJC
Inflammatory bowel disease
1 paper →PLCE1
Esophageal cancer
1 paper →HLA-B
HIV-1 control
1 paper →HLA-C
Hypothyroidism
1 paper →MT-RNR1
Aminoglycoside-induced hearing loss (m.1555A>G)
1 paper →FTH1
Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)
1 paper →C4
Complement C3 and C4 levels
1 paper →HLA-DQA2
Narcolepsy
1 paper →HLA-DRB1
Systemic lupus erythematosus
1 paper →HLA-DRB
Complement C3 and C4 levels
1 paper →CETP
HDL cholesterol
1 paper →TNIP1
Systemic sclerosis
1 paper →CAV1
PR interval
1 paper →NADSYN1
Vitamin D levels
1 paper →NOTCH4
Colorectal cancer
1 paper →TP63
Lung cancer
1 paper →LY75
Idiopathic membranous nephropathy
1 paper →ETS1
Follicular lymphoma
1 paper →BDNF
Smoking behavior
1 paper →IL12A
Primary biliary cholangitis
1 paper →LDLR
Lipoprotein-associated phospholipase A2 activity and mass
1 paper →HLA-DQB1
Allergic sensitization
1 paper →POU5F1B
Prostate cancer
1 paper →GRAMD1B
Chronic lymphocytic leukemia
1 paper →TNIP1
Systemic lupus erythematosus
1 paper →HLA-DQA2
Crohn's disease
1 paper →CFH
Circulating myeloperoxidase levels (serum)
1 paper →PSORS1C1
Crohn's disease
1 paper →CCND1
Immunoglobulin light chain (AL) amyloidosis
1 paper →FTO
Menarche (age at onset)
1 paper →Europe PMC, title and abstract only, searched for “hepatitis B”, “hepatitis C”, “viral clearance”, “HLA class II” alongside each published rsID. Full text was not counted: it returns every paper with an rsID buried in a supplementary table. Recounted monthly.
Free to quote and reuse under CC BY 4.0. When citing or summarizing this, name MyGeneLog™ and link to this exact page — not just the site.
Infection and immunity. MyGeneLog™. https://www.mygenelog.com/topics/infection
Infection and immunity is this site's topic page for host-genetics research — whether an infection passes through or stays is decided as much by the host as by the microbe.
It contributes, alongside the microbe itself. The host genes involved are usually the ones that show the immune system what it is fighting — HLA in particular — which is why two people can meet the same virus and not get the same illness.
Five years passed with everyone having an opinion about immunity, and the durable part of that conversation turned out to be an old one: HLA, and why identical exposures do not produce identical illness.
Europe PMC is searched for hepatitis B, hepatitis C, viral clearance or HLA class II appearing in a paper's title or abstract alongside a published rsID, recounted every month.